194 studies found for:    CO-MED
Show Display Options
Rank Status Study
1 Completed
Has Results
Combining Medications to Enhance Depression Outcomes
Condition: Major Depressive Disorder
Interventions: Drug: SSRI + placebo;   Drug: Escitalopram + Bupropion SR;   Drug: Venlafaxine XR + Mirtazapine
2 Unknown  Memantine for Agitation in Dementia
Condition: Dementia
Interventions: Drug: Memantine;   Drug: Placebo
3 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
Conditions: Measles;   Mumps;   Rubella
Interventions: Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209762).;   Biological: Merck & Co., Inc.'s M-M-R®II, combined measles-mumps-rubella virus vaccine live.;   Biological: Varivax® (Merck & Co., Inc.);   Biological: Havrix®;   Biological: Prevnar 13® (Pfizer Inc.)
4 Recruiting Identification and Characterization of Youth With Extreme Obesity
Conditions: Obesity;   Extreme Obesity
Intervention:
5 Recruiting Course of Obesity and Extreme Obesity in Adolescents
Conditions: Obesity;   Extreme Obesity
Intervention:
6 Not yet recruiting Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery
Condition: Hypoxia
Interventions: Drug: Vasoconstrictor Agents;   Other: Head/neck repositioning;   Other: Increase ETCO2;   Other: IV fluid bolus;   Drug: Additional anesthesia;   Biological: RBC transfusion;   Drug: Increase FiO2
7 Unknown  Safety Study of Raltegravir in HIV/HCV Co-infected Patients
Conditions: HIV;   Hepatitis C
Interventions: Drug: raltegravir;   Drug: Atazanavir/ritonavir
8 Recruiting Study to Evaluate Safety, Pharmacokinetics, and Efficacy of CO-1686 in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients
Condition: Locally Advanced or Metastatic Non-small Cell Lung Cancer.
Intervention: Drug: CO-1686
9 Completed Telehealth Monitoring in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Device: Telehealth monitoring system (Honni Med)
10 Recruiting Economic Aspects of Extreme Obesity in Adolescent
Conditions: Obesity;   Extreme Obesity
Intervention:
11 Active, not recruiting Rule of Carbone Monoxyde in the Ex Vivo Lung Perfusion Reconditionning
Condition: Neurogenic Lung Edema
Intervention: Other: Carbone monoxide
12 Unknown  Prospective Evaluation of Combined Laparoscopy With CO2 Intraoperative Colonoscopy Treatment for Colorectal Lesions
Condition: Colorectal Polyps
Intervention:
13 Completed Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis
Condition: Chronic Bronchitis
Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039);   Drug: Amoxicillin clavulanic acid
14 Recruiting Weight Loss Surgery in Adolescents With Extreme Obesity
Conditions: Obesity;   Extreme Obesity
Interventions: Procedure: bariatric surgery;   Other: conservative care
15 Completed Usefulness of Supportive Text Messages in the Treatment of Depressed Alcoholics
Conditions: Depression;   Alcohol Use Disorder
Intervention: Other: Supportive SMS text messages
16 Completed Acupuncture Versus Placebo Acupuncture During In Vitro Fertilization (IVF) Embryo Transfer
Condition: Infertility
Interventions: Device: Acupuncture (Carbo®);   Device: Placebo acupuncture (Strietberger®)
17 Recruiting Geriatric Intervention in Frail Elderly Patients With Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Other: Geriatric intervention
18 Recruiting AssEssment of CoMorbidities & Atrial ArRhythmiA Burden In DuaL-Chamber PaceD Patients
Condition: Atrial Arrhythmia
Intervention:
19 Recruiting Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
Conditions: HIV-hepatitis Co-infection;   HIV Infections
Intervention:
20 Completed Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options
Condition: HIV Infections
Intervention: Drug: Tipranavir/Ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years